Cargando…
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors
Mesothelin (MSLN) is a cell surface glycoprotein overexpressed in several solid malignancies, including gastric, lung, mesothelioma, pancreatic and ovarian cancers. While several MSLN-targeting therapeutic approaches are in development, only limited efficacy has been achieved in patients. A potentia...
Autores principales: | Hatterer, Eric, Chauchet, Xavier, Richard, Françoise, Barba, Leticia, Moine, Valéry, Chatel, Laurence, Broyer, Lucile, Pontini, Guillemette, Bautzova, Tereza, Juan, Flora, Calloud, Sebastien, Bosson, Nicolas, Charreton, Maud, Masternak, Krzysztof, Buatois, Vanessa, Shang, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153835/ https://www.ncbi.nlm.nih.gov/pubmed/32191151 http://dx.doi.org/10.1080/19420862.2020.1739408 |
Ejemplares similares
-
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
por: Chauchet, Xavier, et al.
Publicado: (2022) -
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
por: Dheilly, Elie, et al.
Publicado: (2018) -
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
por: Dheilly, Elie, et al.
Publicado: (2017) -
Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017) -
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
por: Fischer, Nicolas, et al.
Publicado: (2015)